D2 dopamine receptor polymorphism and brain regional glucose metabolism

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 74, Issue 2, 1997, Pages 162-166

  Noble, Ernest P ^a   Gottschalk, Louis A ^b   Fallon, James H ^c   Ritchie, Terry L ^a   Wu, Joseph C ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

A1+ and A1 allele; brain glucose metabolism; D2 dopamine receptor gene; polymorphism

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; DRUG ABUSE; FEMALE; GENETIC POLYMORPHISM; GLUCOSE METABOLISM; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; ALLELE; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GENETICS; GENOTYPE; METABOLISM; SCINTISCANNING;

DOPAMINE 2 RECEPTOR; GLUCOSE;

ADULT; ALLELES; BRAIN; FEMALE; GENOTYPE; GLUCOSE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030973933     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19970418)74:2<162::AID-AJMG9>3.0.CO;2-W     Document Type: Article

References (30)

1. Adams KM, Gilman S, Koeppe RA, Kluin KJ, Brunberg JA, Dede D, Berent S, Kroll PD (1993): Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcohol Clin Exp Res 17:205-210.
2. 2 dopamine receptor Al allele. Behav Genet 25:45-58.
3. Buchsbaum MS, Potkin SG, Siegel BV Jr, Lohr J, Katz M, Gottschalk LA, Gulasekaram B, Marshall JF, Lottenberg S, Teng CY, Abel L, Pion L, Bunney WE Jr (1992): Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry 15:205-217.
4. Fallon JH, Loughlin SE (1987): Monoamine innervation of cerebral cortex and a theory of the role of monoamines in cerebral cortex and basal ganglia. In Jones EG, Peters A (eds): "Cerebral Cortex." New York: Plenum, pp 41-127.
5. Fletcher PC, Frith CD, Grasby PM, Shallice T, Frackowiak RS, Dolan RJ (1995): Brain systems for encoding and retrieval of auditory-verbal memory. An in vivo study in humans. Brain 118:401-416.
6. Friston KJ (1994): Statistical parametric mapping. In Thatcher RW, Hallet M, Zefforo T, John ER, Huerta M (eds): "Functional Neuroimaging: Technical Foundations." 1st edition, New York: Academic Press, pp 77-93.
7. Good P (1994): "Permutation Test: A Practical Guide to Resampling Methods for Testing Hypotheses." Berlin: Springer-Verlag.
8. 2 dopamine receptor gene is located on chromosome 11 at q22-q23 and identified a Taql RFLP. Am J Hum Genet 45:778-785.
9. Grandy DK, Zhang Y, Civelli O (1993): PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 2:2197.
10. 2 receptors in basal ganglia and cortex of human brain. J Pharmacol Exp Ther 257:1253-1263.
11. Maeda T, Ikemoto K, Satoh K, Kitahama K, Geffard M (1995): Dopaminergic innervation of primate cerebral cortex. In Segawa M, Nomura Y (eds): "Age-Related Dopamine-Dependent Disorders." Basel: Karger, pp 147-159.
12. Matsui T, Hirano A (1978): "An Atlas of the Human Brain for Computerized Tomography." Tokyo: Igaku-Shoin.
13. 2 receptor gene in samples of female and male alcoholics. Am J Med Genet (Neuropsychiat Genet) 60:267-271.
14. Neuchterlein K, Parasurama R, Jiang Q (1983): Visual sustained attention: Image degradation produces rapid decrements over time. Science 220:327-329.
15. Noble EP (1996): The gene that rewards alcoholism. Scientific American Science & Medicine 3:52-61.
16. 2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48:648-654.
17. 2 dopamine receptor Al allele. Am J Hum Genet 54:658-668.
18. Pollack S, Bruce P, Borenstein M, Lieberman J (1994): The resampling method of statistical analysis. Psychopharmacol Bull 30:227-234.
19. Schwartz, WJ, Sharp FR, Gunn RH, Evarts EV (1976): Lesions of ascending dopaminergic pathways decrease forebrain glucose uptake. Nature 261:155-157.
20. Schwartz WJ, Smith CB, Davidsen L, Savaki H, Sokoloff L, Mata M, Fink DJ, Gainer H (1979): Metabolic mapping of functional activity in the hypothalamo-neurophysiological system in the rat. Science 205:723-725.
21. Smiley JF, Williams SM, Szigeti K, Goldman-Rakic P (1992): Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex. J Comp Neurol 321:325-335.
22. Sokoloff L (1984): Modeling metabolic processes in the brain in vivo. Annu Neurol 15:S1-11.
23. Stuss DT, Benson DF (1986): "The Frontal Lobes." New York: Raven Press, pp 121-138.
24. Talairach J, Tournoux P (1988): "Co-planar Steroetaxic Atlas of the Human Brain." Stuttgart: Thleme.
25. Uhl GR, Elmer GI, LaBuda MC, Pickens RW (1995): Genetic influences in drug abuse. In Bloom FE, Kupfer DJ (eds): "Psychopharmacology: The Fourth Generation of Progress." New York: Raven Press, pp 1793-1806.
26. Volkow ND, Hitzemann R, Wang G-J, Fowler JS, Wolf AP, Dewey SL, Handlesman L (1992): Long-term frontal brain metabolic changes in cocaine abusers. Synapse 11:184-190.
27. 2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177.
28. Volkow ND, Wang, G-J, Hitzemann R, Fowler JS, Overall JE, Burr G, Wolf AP (1994): Recovery of brain glucose metabolism in detoxified alcoholics. Am J Psychiatry 151:178-183.
29. Widman JC (1988): Monte Carlo simulation in nuclear medicine (1988). In: Morin RL (ed): "Monte Carlo Simulation in the Radiological Sciences." Boco Raton, FL: CRC Press, pp 193-208.
30. 11C-glucose. Acta Psychiatr Scand 78: 234-241.